Advertising: be brief, be bold
July 22, 2009Sales and Marketing Pfizer, advertising, branding
In the pharma industry, do we believe that the gap between what our businesses promise and what results our businesses …
NICE approves MabThera for leukaemia
July 22, 2009Research and Development, Sales and Marketing MabThera, NICE
NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
Pharmaceutical manufacturing: news in brief
July 22, 2009Manufacturing and Production GW
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from GW and Viva Biopharm, GMP problems at an …
Tracleer expansion fuels Actelion growth
July 22, 2009Sales and Marketing Actelion, Tracleer
Sales of pulmonary arterial hypertension treatment Tracleer are continuing to grow worldwide, helping to boost the fortunes of Actelion. The …
PharmaTelevision launches new premium content service
July 21, 2009Medical Communications Pharma TV, digi
PharmaTelevision, an online TV channel dedicated to coverage of the pharmaceutical, biotech and related industries is to launch a new …
Phase Forward buys Covance unit for $10m
July 21, 2009Research and Development CRO, Phase Forward
US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …
Nycomed to invest in Russian manufacturing facility
July 21, 2009Manufacturing and Production Nycomed, Russia
Swiss pharmaceutical company Nycomed is already a big player in the Russian drug market, and looks set to consolidate that …
Roche eyes expanded colon cancer label for Xeloda
July 20, 2009Research and Development, Sales and Marketing Roche, Xeloda
Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …
Tonic to join Huntsworth group as global PR brand
July 20, 2009Medical Communications, Sales and Marketing Huntsworth, Tonic
Independent public relations and communications agency Tonic has been acquired by the Huntsworth group.The Huntsworth group has grown rapidly over …
Jubilant makes solid start to fiscal 2010
July 20, 2009Manufacturing and Production, Research and Development Jubilant
Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …
Drug repositioning a ‘key strategy’ for pharma
July 17, 2009Research and Development Datamonitor, strategy
With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …
The Trillion Dollar Project: US healthcare reform begins
July 17, 2009Sales and Marketing Obama, US, healthcare, reform
The battle to determine how the US healthcare system will be reformed is heating up, with dozens of interest groups …
Merck signs anticoagulant collaboration
July 17, 2009Research and Development, Sales and Marketing Merck, cv
Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …
Bayer to launch OTC omeprazole in Germany
July 17, 2009Sales and Marketing Bayer, OTC
Bayer Vital, the marketing arm of Bayer HealthCare, is to launch the proton pump inhibitor omeprazole as an over-the-counter heartburn …
Effient approved in US
July 17, 2009Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly
Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
Depakote’s decline depresses Abbott
July 16, 2009Sales and Marketing Abbott
A rapid drop in sales for epilepsy drug Depakote cast a shadow over second quarter results from Abbott Laboratories. While …
Rheumatoid arthritis delays criticised
July 16, 2009Sales and Marketing NHS, RA
An official report into the treatment of people with rheumatoid arthritis (RA) has criticised a lack of co-ordination between different …
Health minister Lord Darzi resigns
July 16, 2009NHS, healthcare
Lord Darzi has quit his high-profile role as health minister in order to concentrate on his patients, and will in …
NICE bypassed in radical innovation boost
July 16, 2009Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta
Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
